Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00037050 | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria | PHASE3 | COMPLETED | 739 | — | — | Apr 1, 2002 | Jul 1, 2005 | Sep 14, 2009 | - | — |
| Name | Type | Description |
|---|---|---|
| Linezolid | DRUG | - |
| Vancomycin | DRUG | - |
| Oxacillin | DRUG | - |
| Dicloxacillin | DRUG | - |
Inclusion Criteria: * Patients with a central indwelling catheter with signs and symptoms of infection Exclusion Criteria: * Patients with tunneled catheter which cannot be removed. * Patients with evidence of endovascular infection including endocarditis. * Patients with infection of permanent i...